"10.1371_journal.ppat.1005276","plos pathogens","2015-11-20T00:00:00Z","Rami Sommerstein; Lukas Flatz; Melissa M Remy; Pauline Malinge; Giovanni Magistrelli; Nicolas Fischer; Mehmet Sahin; Andreas Bergthaler; Sebastien Igonet; Jan ter Meulen; Dorothée Rigo; Paolo Meda; Nadia Rabah; Bruno Coutard; Thomas A Bowden; Paul-Henri Lambert; Claire-Anne Siegrist; Daniel D Pinschewer","Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; World Health Organization Collaborating Centre for Vaccine Immunology, University of Geneva, Geneva, Switzerland; Division of Experimental Virology, Department of Biomedicine, University of Basel, Basel, Switzerland; Novimmune SA, Plan-Les-Ouates, Switzerland; Institut Pasteur, Département de Virologie, Unité de Virologie Structurale and CNRS UMR 3569 Virologie, Paris, France; Institute of Virology, Philipps University Marburg, Marburg, Germany; Department of Cell Physiology and Metabolism, University of Geneva, Geneva, Switzerland; AFMB, UMR7257 CNRS/Aix Marseille Université, Marseille, France; Division of Structural Biology, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom","Conceived and designed the experiments: RS LF MMR PMa GM NF AB JtM BC PMe PHL CAS DDP. Performed the experiments: RS LF MMR PMa MS NR AB DR. Analyzed the data: PMa GM NF AB DR PMe PHL CAS DDP. Contributed reagents/materials/analysis tools: SI JtM NR BC TAB. Wrote the paper: RS LF MMR DDP.","I have read the journals policy and the authors of this manuscript have the following competing interests: LF, AB and DDP are shareholders and DDP also is a consultant to Hookipa Biotech AG commercializing arenavirus-based vector technology. LF, AB as well as DDP are listed as inventors on a related patent. PHL acts as a consultant and supervisory board member of Hookipa Biotech AG. The remaining authors declare no competing financial interests. This does not alter our adherence to all PLOS policies on sharing data and materials.","2015","11","Rami Sommerstein","RS",18,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
